Bacterial Infections in Decompensated Cirrhosis: Clinical Profile, Microbiology, and Antimicrobial Resistance

Anubhav Dabas1, Mohmad Sejarali Sayeed2, Praful Kumar Chavhan3

  • 1Gastroenterology, Oxygen Hospital, Rohtak, IND.

Cureus
|June 15, 2026
PubMed

Insights

Nearly half of hospitalized patients with decompensated cirrhosis in North India develop bacterial infections, leading to significantly higher mortality. High rates of multidrug-resistant and extensively drug-resistant organisms necessitate updated treatment strategies.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Microbiology

Background:

  • Hospitalized patients with decompensated cirrhosis are at high risk for bacterial infections.
  • The Indian subcontinent is a recognized hotspot for antimicrobial resistance (AMR), yet prospective data are limited.
  • Understanding infection prevalence and resistance patterns is crucial for patient management.

Purpose of the Study:

  • To investigate the prevalence, microbiological characteristics, and outcomes of bacterial infections in hospitalized patients with decompensated cirrhosis in North India.
  • To identify predictors of infection and mortality in this patient population.
  • To assess the patterns of antimicrobial resistance, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) organisms.

Main Methods:

  • A prospective observational study conducted over 18 months, enrolling 176 adult patients with decompensated cirrhosis.
  • Analysis of clinical profiles, infection prevalence, microbiological isolates, antimicrobial susceptibility, and in-hospital outcomes.
  • Multivariate logistic regression was used to identify independent predictors of infection and mortality.

Main Results:

  • Bacterial infections were documented in 46.6% of patients, associated with significantly higher in-hospital mortality (37.8% vs. 3.2%).
  • Predominant isolates included *Escherichia coli* and *Klebsiella* spp.
  • High rates of antimicrobial resistance were observed: 57.5% overall, with 45.0% MDR and 12.5% XDR organisms. Ceftriaxone susceptibility for *E. coli* was low (27.3%).

Conclusions:

  • Bacterial infections are common and associated with poor outcomes in North Indian patients with decompensated cirrhosis.
  • The high prevalence of MDR and XDR organisms makes standard empirical antibiotic therapy inadequate.
  • Urgent implementation of region-specific antibiograms, enhanced antimicrobial stewardship, and infection prevention strategies is critical.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...